Estimates of infectious disease risk factors in US blood donors

被引:143
|
作者
Williams, AE
Thomson, RA
Schreiber, GB
Watanabe, K
Bethel, J
Lo, A
Kleinman, SH
Hollingsworth, CG
Nemo, GJ
机构
[1] GREATER CHESAPEAKE & POTOMAC REG,BALTIMORE,MD
[2] WESTAT CORP,ROCKVILLE,MD
[3] AMER RED CROSS,BLOOD SERV,LOS ANGELES,CA 90006
[4] NHLBI,NIH,BETHESDA,MD 20892
来源
关键词
D O I
10.1001/jama.277.12.967
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective.-Individuals who do not respond accurately to questions about infectious disease risk factors at the time of blood donation represent a potential threat to the safety of the blood supply. This study was designed to estimate the prevalence of undetected behavioral and other risks in current blood donors. Design.-Anonymous mail surveys to collect demographic, medical, and behavioral information were administered to individuals who had donated blood within the previous 2 months. Sampling weights were used in the analysis to adjust for differential sampling and response rates among demographic groups to provide prevalence estimates for the donor population. Setting.-Five geographically and demographically diverse US blood centers. Participants.-A stratified probability sample of 50 162 allogeneic blood donors. Main Outcome Measures.-Estimated prevalence rates for risk behaviors that would have been a basis for deferral if reported at the time of the donor screening interview (deferrable risk). Results.-Completed questionnaires were received for 34 726 donors (69.2% of the sample). A total of 186 per 10 000 respondents (1.9%) reported a deferrable risk that was present at the time of their past donation, while 39 per 10 000 (0.4%) reported this behavior within the 3 months prior to donation. Rates (with 95% confidence intervals [CIs]) of deferrable risk behaviors were 1.4 (95% CI, 1.2-1.6) times higher for men than women, 1.6 (95% CI, 1.3-2.0) times higher for first-time vs repeat donors, 2.7 (95% CI, 2.0-3.6) times higher for donors with reactive screening tests, and 7.6 (95% CI, 3.6-15.8) times higher for donors who used the confidential unit exclusion option. Conclusions.-Despite the high degree of transfusion safety in the United States today, a measurable percentage of active blood donors when assessed by anonymous survey report risks for human immunodeficiency virus and other infections not reported at the time of screening, suggesting the need for further refinements in the blood donor qualification process.
引用
收藏
页码:967 / 972
页数:6
相关论文
共 50 条
  • [21] BLOOD DONORS CONTACT WITH INFECTIOUS HEPATITIS
    LANGMUIR, AD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1961, 177 (10): : 733 - &
  • [22] Infectious disease markers in autologous blood donors and first-time volunteer blood donors:: 14 years' experience in a blood center
    Hernández, JM
    Cid, J
    Claparols, M
    Mallafré, E
    Pla, R
    [J]. HAEMATOLOGICA, 2004, 89 (07) : 889 - 891
  • [23] Evaluation of residual infectious risk among blood donors in National Center of Blood Transfusion in Conakry
    Loua, A
    Sow, EML
    Magassouba, FB
    Camara, M
    Baldé, MA
    [J]. TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2004, 11 (02) : 98 - 100
  • [24] Controlling Infectious Risk in Transfusion: Assessing the Effectiveness of Skin Disinfection in Blood Donors
    Arghittu, Antonella
    Dettori, Marco
    Deriu, Grazia Maria
    Soddu, Serena
    Manca, Pietro Carmelo
    Carboni, Anna Angela
    Collu, Irene
    Palmieri, Alessandra
    Deiana, Giovanna
    Azara, Antonio
    Castiglia, Paolo
    Masia, Maria Dolores
    [J]. HEALTHCARE, 2022, 10 (05)
  • [25] Risk factors and epidemiology of human T-lymphotropic virus types 1 and 2 in US blood donors
    Farnaz Vahidnia
    Susan L Stramer
    Debra A Kessler
    David E Krysztof
    Roger Y Dodd
    Ed Notari
    Simone Glynn
    Brian Custer
    [J]. Retrovirology, 12
  • [26] Risk factors and epidemiology of human T-lymphotropic virus types 1 and 2 in US blood donors
    Vahidnia, Farnaz
    Stramer, Susan L.
    Kessler, Debra A.
    Krysztof, David E.
    Dodd, Roger Y.
    Notari, Ed
    Glynn, Simone
    Custer, Brian
    [J]. RETROVIROLOGY, 2015, 12
  • [27] Cardiovascular disease risk assessment and prevention in blood donors
    Kessler, Debra A.
    Ortiz, Caroline
    Grima, Kathleen
    Vlahov, David
    Nandi, Vijay
    Jones, Robert
    Hillyer, Christopher D.
    Shaz, Beth H.
    [J]. TRANSFUSION, 2012, 52 (10) : 2174 - 2182
  • [28] INFECTIOUS DISEASE MARKERS IN DONORS OF AUTOLOGOUS BLOOD COMPONENTS OTHER THAN PREOPERATIVE AUTOLOGOUS BLOOD
    Zimmermann, R.
    Hofmann, P.
    Weisbach, V
    Strasser, E.
    Weiss, D.
    Eckstein, R.
    [J]. VOX SANGUINIS, 2010, 99 : 272 - 272
  • [29] Evaluation of blood supply operation and infectious disease markers in blood donors during the Egyptian revolution
    Hussein, Eiman
    Teruya, Jun
    [J]. TRANSFUSION, 2012, 52 (11) : 2321 - 2328
  • [30] Risk factors for chronic kidney disease in kidney donors
    Lee, Jang Han
    You, Mi Hyun
    Kim, Song Cheol
    Han, Duck Jong
    Chang, Jai Won
    Yang, Won Seok
    Park, Su Kil
    Lee, Sang Koo
    Park, Jung Sik
    Kim, Soon Bae
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 393 - 393